Related Experiment Video
Updated: Jun 5, 2026

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and
Pierre-Emmanuel Rautou1, Aurélie S Leroyer, Bhama Ramkhelawon
1Paris Centre de recherche Cardiovasculaire à l'HEGP, INSERM U970, 56, rue Leblanc, 75737 Paris cedex 15, France. chantal.boulanger@inserm.fr.
Rationale And Objective:
Membrane-shed submicron microparticles (MPs) released following cell activation or apoptosis accumulate in atherosclerotic plaques, where they stimulate endothelial proliferation and neovessel formation. The aim of the study was to assess whether or not MPs isolated from human atherosclerotic plaques contribute to increased endothelial adhesion molecules expression and monocyte recruitment.
Method And Results:
Human umbilical vein and coronary artery endothelial cells were exposed to MPs isolated from endarterectomy specimens (n=62) and characterized by externalized phosphatidylserine. Endothelial exposure to plaque, but not circulating, MPs increased ICAM-1 levels in a concentration-dependant manner (3.4-fold increase) without affecting ICAM-1 mRNA levels. Plaque MPs harbored ICAM-1 and transferred this adhesion molecule to endothelial cell membrane in a phosphatidylserine-dependent manner. MP-borne ICAM-1 was functionally integrated into cell membrane as demonstrated by the increased ERK1/2 phosphorylation following ICAM-1 ligation. Plaque MPs stimulated endothelial monocyte adhesion both in culture and in isolated perfused mouse carotid. This effect was also observed under flow condition and was prevented by anti-LFA-1 and anti-ICAM-1 neutralizing antibodies. MPs isolated from symptomatic plaques were more potent in stimulating monocyte adhesion than MPs from asymptomatic patients. Plaque MPs did not affect the release of interleukin-6, interleukin-8, or MCP-1, nor the expression of VCAM-1 and E-selectin.
Conclusion:
These results demonstrate that MPs isolated from human atherosclerotic plaques transfer ICAM-1 to endothelial cells to recruit inflammatory cells and suggest that plaque MPs promote atherosclerotic plaque progression.
Insights
Microparticles (MPs) from atherosclerotic plaques transfer intercellular adhesion molecule-1 (ICAM-1) to endothelial cells, increasing monocyte adhesion and promoting plaque progression. Symptomatic plaque MPs are more potent drivers of this inflammatory process.
Area of Science:
- Cardiovascular Biology
- Cell Biology
- Immunology
Background:
- Submicron microparticles (MPs) shed from activated or apoptotic cells accumulate in atherosclerotic plaques.
- These plaque-derived MPs contribute to endothelial proliferation and neovascularization.
Purpose of the Study:
- To investigate if MPs from human atherosclerotic plaques enhance endothelial expression of adhesion molecules.
- To determine if these plaque MPs increase monocyte recruitment to the endothelium.
Main Methods:
- Human umbilical vein and coronary artery endothelial cells were treated with MPs from human atherosclerotic plaques (n=62).
- Intercellular adhesion molecule-1 (ICAM-1) levels, mRNA, and transfer were assessed.
- Monocyte adhesion assays were performed in static and flow conditions using human and mouse models.
Main Results:
- Plaque MPs, not circulating MPs, significantly increased endothelial ICAM-1 levels (3.4-fold) in a concentration-dependent manner.
- Plaque MPs transferred functional ICAM-1 to endothelial cells, enhancing monocyte adhesion.
- MPs from symptomatic plaques showed greater potency in stimulating monocyte adhesion compared to those from asymptomatic plaques.
Conclusions:
- MPs from human atherosclerotic plaques facilitate monocyte recruitment by transferring ICAM-1 to endothelial cells.
- These findings suggest that plaque-derived MPs play a critical role in the progression of atherosclerotic plaques.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Inflammation

